SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-107164
Filing Date
2023-10-05
Accepted
2023-10-05 16:05:13
Documents
14
Period of Report
2023-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2327726d1_8k.htm   iXBRL 8-K 35714
2 EXHIBIT 4.3 tm2327726d1_ex4-3.htm EX-4.3 96419
3 EXHIBIT 99.1 tm2327726d1_ex99-1.htm EX-99.1 10557
  Complete submission text file 0001104659-23-107164.txt   348094

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rsls-20230929.xsd EX-101.SCH 3048
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rsls-20230929_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rsls-20230929_pre.xml EX-101.PRE 22381
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2327726d1_8k_htm.xml XML 3220
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 231311360
SIC: 3841 Surgical & Medical Instruments & Apparatus